Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Language
Publication year range
1.
PLoS One ; 9(4): e94636, 2014.
Article in English | MEDLINE | ID: mdl-24728320

ABSTRACT

INTRODUCTION: After antiretroviral therapy (ART) became available, there was a decline in the number of deaths in persons infected with HIV. Thereafter, there was a decrease in the proportion of deaths attributed to opportunistic infections and an increase in the proportion of deaths attributed to chronic comorbidities. Herein we extend previous observations from a nationwide survey on temporal trends in causes of death in HIV-infected patients in Brazil. METHODS: We describe temporal trends in causes of death among adults who had HIV/AIDS listed in the death certificate to those who did not. All death certificates issued in Brazil from 1999 to 2011 and listed in the national mortality database were included. Generalized linear mixed-effects logistic models were used to study temporal trends in proportions. RESULTS: In the HIV-infected population, there was an annual adjusted average increase of 6.0%, 12.0%, 4.0% and 4.1% for cancer, external causes, cardiovascular diseases (CVD) and diabetes mellitus (DM), respectively, compared to 3.0%, 4.0%, 1.0% and 3.9%, in the non-HIV group. For tuberculosis (TB), there was an adjusted average increase of 0.3%/year and a decrease of 3.0%/year in the HIV and the non-HIV groups, respectively. Compared to 1999, the odds ratio (OR) for cancer, external causes, CVD, DM, or TB in the HIV group were, respectively, 2.31, 4.17, 1.76, 2.27 and 1.02, while for the non-HIV group, the corresponding OR were 1.31, 1.63, 1.14, 1.62 and 0.67. Interactions between year as a continuous or categorical variable and HIV were significant (p<0.001) for all conditions, except for DM when year was considered as a continuous variable (p = 0.76). CONCLUSIONS: Non HIV-related co-morbidities continue to increase more rapidly as causes of death among HIV-infected individuals than in those without HIV infection, highlighting the need for targeting prevention measures and surveillance for chronic diseases among those patients.


Subject(s)
Cardiovascular Diseases/complications , Cause of Death , HIV Infections/complications , HIV Infections/mortality , Adolescent , Adult , Aged , Brazil/epidemiology , Cardiovascular Diseases/epidemiology , Diabetes Mellitus/epidemiology , Female , HIV Infections/epidemiology , Humans , Male , Middle Aged , Odds Ratio , Public Health Surveillance , Young Adult
2.
AIDS Res Ther ; 10(1): 32, 2013 Dec 13.
Article in English | MEDLINE | ID: mdl-24330597

ABSTRACT

The success of highly active antiretroviral therapy (HAART) has determined a dramatic decline in AIDS- and immunodeficiency-related causes of death in the HIV-infected population. As life-expectancy increases, such individuals have become gradually exposed not only to the effects of aging itself, but also to the influence of environmental risk factors, which are known to act in the general population. These features can lead to obesity, diabetes mellitus and ultimately cardiovascular diseases (CVD). Metabolic complications and abnormal fat distribution were frequently observed after a few years of antiretroviral therapy and, as the array of antiretroviral drugs became broader, long term metabolic alterations are becoming far more common worldwide. Nevertheless, the risk of not being on HAART is overwhelmingly greater than the metabolic adverse events in terms of morbidity and mortality events. HIV/HAART-induced metabolic unbalances overlap in some extent the components of Metabolic Syndrome (MetS) and its high rates in the HIV population place infected individuals in an elevated CVD risk category. MetS can explain at least in part the emergence of CVD as the major morbidity and mortality conditions in the HIV population. In this review we convey information on the underlying aspects of MetS during HIV infection, highlighting some physiopathological and epidemiological features of this comorbidity along with the role played by HIV itself and the synergy action of some antiretroviral drugs. Considerations on MetS management in the HIV population are also depicted.

3.
PLoS One ; 6(5): e19216, 2011 May 06.
Article in English | MEDLINE | ID: mdl-21573150

ABSTRACT

Galectin-3 is a ß-galactoside-binding protein that has been shown to regulate pathophysiological processes, including cellular activation, differentiation and apoptosis. Recently, we showed that galectin-3 acts as a potent inhibitor of B cell differentiation into plasma cells. Here, we have investigated whether galectin-3 interferes with the lymphoid organization of B cell compartments in mesenteric lymph nodes (MLNs) during chronic schistosomiasis, using WT and galectin-3(-/-) mice. Schistosoma mansoni synthesizes GalNAcß1-4(Fucα1-3)GlcNAc(Lac-DiNAc) structures (N-acetylgalactosamine ß1-4 N-acetylglucosamine), which are known to interact with galectin-3 and elicit an intense humoral response. Antigens derived from the eggs and adult worms are continuously drained to MLNs and induce a polyclonal B cell activation. In the present work, we observed that chronically-infected galectin-3(-/-) mice exhibited a significant reduced amount of macrophages and B lymphocytes followed by drastic histological changes in B lymphocyte and plasma cell niches in the MLNs. The lack of galectin-3 favored an increase in the lymphoid follicle number, but made follicular cells more susceptible to apoptotic stimuli. There were an excessive quantity of apoptotic bodies, higher number of annexin V(+)/PI(-) cells, and reduced clearance of follicular apoptotic cells in the course of schistosomiasis. Here, we observed that galectin-3 was expressed in non-lymphoid follicular cells and its absence was associated with severe damage to tissue architecture. Thus, we convey new information on the role of galectin-3 in regulation of histological events associated with B lymphocyte and plasma cell niches, apoptosis, phagocytosis and cell cycle properties in the MLNs of mice challenged with S.mansoni.


Subject(s)
B-Lymphocytes/cytology , B-Lymphocytes/metabolism , Galectin 3/metabolism , Lymph Nodes/cytology , Schistosoma mansoni/pathogenicity , Schistosomiasis mansoni/metabolism , Animals , Apoptosis/genetics , Apoptosis/physiology , Cells, Cultured , Female , Flow Cytometry , Fluorescent Antibody Technique , Galectin 3/genetics , Immunohistochemistry , Male , Mice , Phagocytosis/genetics , Phagocytosis/physiology , Plasma Cells/cytology , Plasma Cells/metabolism , Schistosomiasis mansoni/genetics
4.
J Parasitol ; 89(4): 832-6, 2003 Aug.
Article in English | MEDLINE | ID: mdl-14533699

ABSTRACT

In this article, we describe the findings obtained using immunoblot analysis in the diagnosis of canine visceral leishmaniasis (VL) and its correlation with serological titer and clinical status. We found that all animals bearing amastigote forms recognized antigens with 29 and 32 kDa and that this pattern can be exploited for diagnostic and epidemiological purposes. The recognition of the 29- and 32-kDa antigens was verified even in seronegative dogs and preceded seroconversion in periods ranging from several months to 2 yr. We found a correlation between serological titer and parasite burden. Although no correlation between antigenic recognition pattern and clinical status was observed, immunoblot analysis proved to be a reliable test to detect antibodies against Leishmania sp. antigens in dogs from areas with endemic VL.


Subject(s)
Antibodies, Protozoan/blood , Antigens, Protozoan , Dog Diseases/diagnosis , Immunoblotting/veterinary , Leishmania/immunology , Leishmaniasis, Visceral/veterinary , Animals , Antigens, Protozoan/immunology , Bone Marrow/parasitology , Brazil/epidemiology , Dog Diseases/epidemiology , Dogs , Fluorescent Antibody Technique/veterinary , Leishmania/isolation & purification , Leishmaniasis, Visceral/diagnosis , Leishmaniasis, Visceral/epidemiology , Lymph Nodes/parasitology
5.
Rev Inst Med Trop Sao Paulo ; 45(2): 79-83, 2003.
Article in English | MEDLINE | ID: mdl-12754572

ABSTRACT

Barra de Guaratiba is a coastal area of the city of Rio de Janeiro where American visceral leishmaniasis (AVL) is endemic. Although control measures including killing of dogs and use of insecticides have been applied at this locality, the canine seroprevalence remains at 25% and during 1995 and 1997 eight autochthonous human cases were notified. In order to evaluate factors related to the increase of the risk for Leishmania (Leishmania) chagasi infection in dogs we have screened 365 dogs by anti-Leishmania immunofluorescent antibody test (IFAT) and captured sandflies in the domestic and peridomestic environment. Some variables related to the infection were assessed by uni- and multivariate analysis. The distance of the residence from the forest border, its altitude and the presence of the opossum Didelphis marsupialis in the backyard, were found predictor factors for L. (L.) chagasi infection in dogs in Barra de Guaratiba. The presence of Lutzomyia longipalpis in the peridomestic environment indicates the possibility of appearence of new human cases. Our data also suggest the presence of a sylvatic enzootic cycle at this locality.


Subject(s)
Dog Diseases/epidemiology , Leishmania/isolation & purification , Leishmaniasis, Visceral/veterinary , Animals , Brazil/epidemiology , Disease Vectors , Dog Diseases/parasitology , Dog Diseases/transmission , Dogs , Endemic Diseases/veterinary , Female , Fluorescent Antibody Technique, Direct , Humans , Leishmaniasis, Visceral/epidemiology , Leishmaniasis, Visceral/transmission , Male , Opossums/parasitology , Psychodidae , Risk Factors , Seroepidemiologic Studies
6.
Rev. Inst. Med. Trop. Säo Paulo ; 45(2): 79-83, Mar.-Apr. 2003. tab, graf
Article in English | LILACS | ID: lil-333182

ABSTRACT

Barra de Guaratiba is a coastal area of the city of Rio de Janeiro where American visceral leishmaniasis (AVL) is endemic. Although control measures including killing of dogs and use of insecticides have been applied at this locality, the canine seroprevalence remains at 25 percent and during 1995 and 1997 eight autochthonous human cases were notified. In order to evaluate factors related to the increase of the risk for Leishmania (Leishmania) chagasi infection in dogs we have screened 365 dogs by anti-Leishmania immunofluorescent antibody test (IFAT) and captured sandflies in the domestic and peridomestic environment. Some variables related to the infection were assessed by uni- and multivariate analysis. The distance of the residence from the forest border, its altitude and the presence of the opossum Didelphis marsupialis in the backyard, were found predictor factors for L. (L.) chagasi infection in dogs in Barra de Guaratiba. The presence of Lutzomyia longipalpis in the peridomestic environment indicates the possibility of appearence of new human cases. Our data also suggest the presence of a sylvatic enzootic cycle at this locality


Subject(s)
Animals , Humans , Male , Female , Dogs , Dog Diseases , Leishmania , Leishmaniasis, Visceral , Brazil , Disease Vectors , Dog Diseases , Endemic Diseases , Fluorescent Antibody Technique, Direct , Leishmania , Leishmaniasis, Visceral , Opossums , Psychodidae , Risk Factors , Seroepidemiologic Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...